BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37668180)

  • 1. An obstetric-specific surgical Apgar score predicts maternal morbidity from cesarean hysterectomy for placenta accreta spectrum.
    Munoz JL; Curbelo J; Ramsey PS
    Int J Gynaecol Obstet; 2024 Mar; 164(3):912-917. PubMed ID: 37668180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal-occult placenta accreta: a clandestine source of maternal morbidity.
    Larish A; Horst K; Brunton J; Schenone M; Branda M; Mehta R; Packard A; VanBuren W; Norgan A; Shahi M; Missert A; Pompeian R; Greenwood J; Theiler R
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100924. PubMed ID: 36934974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel transverse uterine incisions, a novel approach for managing heavy hemorrhage and preserving the uterus: A retrospective cohort study for patients with anterior placenta previa and accreta.
    Peng X; Chen D; Xu J; Liu X; You Y; Peng B
    Medicine (Baltimore); 2019 Nov; 98(44):e17742. PubMed ID: 31689824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies.
    Munoz JL; Kimura AM; Julia J; Tunnell C; Hernandez B; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10692-10697. PubMed ID: 36521848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
    Marcellin L; Delorme P; Bonnet MP; Grange G; Kayem G; Tsatsaris V; Goffinet F
    Am J Obstet Gynecol; 2018 Aug; 219(2):193.e1-193.e9. PubMed ID: 29733839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS).
    Munoz JL; Pfeiffer AF; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8640-8644. PubMed ID: 34657560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planned versus urgent deliveries in placenta previa: maternal, surgical and neonatal results.
    Durukan H; Durukan ÖB; Yazıcı FG
    Arch Gynecol Obstet; 2019 Dec; 300(6):1541-1549. PubMed ID: 31655886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned versus Unplanned Delivery for Placenta Accreta Spectrum.
    Fishel Bartal M; Papanna R; Zacharias NM; Soriano-Calderon N; Limas M; Blackwell SC; Chen HY; Chauhan SP; Sibai BM
    Am J Perinatol; 2022 Feb; 39(3):252-258. PubMed ID: 32702770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum.
    Munoz JL; Ramsey PS; Greebon LJ; Salazar E; McCann GA; Byrne JJ
    Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():32-35. PubMed ID: 38100939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.
    Lucidi A; Jauniaux E; Hussein AM; Coutinho CM; Tinari S; Khalil A; Shamshirsaz A; Palacios-Jaraquemada JM; D'Antonio F
    Ultrasound Obstet Gynecol; 2023 Nov; 62(5):633-643. PubMed ID: 37401769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternate surgical approach to reduce hemorrhage and complications during cesarean hysterectomy for adherent placenta.
    Saha PK; Bagga R; Kalra JK; Arora A; Singla R; Suri V; Jain K; Kumar P; Gupta N; Jain A; Singh T; Mavuduru RS
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():215-220. PubMed ID: 30007249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal outcomes in the surgical management of placenta accreta spectrum disorders: a retrospective single-center observational study from 468 Vietnamese pregnancies beyond 28 weeks of gestation.
    Nguyen PN; Vuong ADB; Pham XTT
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):228. PubMed ID: 38566074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Matsuzaki S; Vestal NL; Sangara RN; Mandelbaum RS; Matsushima K; Klar M; Ouzounian JG
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2234-2243. PubMed ID: 34622939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anesthesia selection on neonatal outcomes in cesarean hysterectomies for placenta accreta spectrum (PAS).
    Munoz JL; Hernandez B; Curbelo J; Ramsey PS; Ireland KE
    J Perinat Med; 2022 Nov; 50(9):1210-1214. PubMed ID: 35607729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripartum hysterectomy clinical characteristics and outcomes- a hospital based retrospective audit study.
    Nor AM; Jagdeesh K; Mohd FAS; Kamraul AK; Yusmadi A; Noraslawati R; Malina O; Roziana R
    Med J Malaysia; 2023 Nov; 78(6):756-762. PubMed ID: 38031217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the placenta accreta spectrum score and estimated blood loss in placenta accreta spectrum patients with placenta previa: a retrospective cohort study.
    Huang F; Wang J; Xiong Q; Wang W; Xu Y; Zhuo J; Xia Q; Liu X
    J Anesth; 2022 Dec; 36(6):715-722. PubMed ID: 36173551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.
    Sentilhes L; Seco A; Azria E; Beucher G; Bonnet MP; Branger B; Carbillon L; Chiesa C; Crenn-Hebert C; Dreyfus M; Dupont C; Fresson J; Huissoud C; Langer B; Morel O; Patrier S; Perrotin F; Raynal P; Rozenberg P; Rudigoz RC; Vendittelli F; Winer N; Deneux-Tharaux C; Kayem G;
    Am J Obstet Gynecol; 2022 Jun; 226(6):839.e1-839.e24. PubMed ID: 34914894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.